Search results
European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential...
Benzinga via Yahoo Finance· 1 year agoThe European Union bloc is reportedly negotiating an amended deal with Pfizer Inc (NYSE: PFE) and...
Updated Covid vaccines from Pfizer and Moderna rolled out nationwide: Latest
The Independent UK via AOL· 9 months agoNew Covid boosters from Pfizer and Moderna are now available at pharmacies nationwide. The Centers...
Is Pfizer a Bad News Buy Right Now?
Motley Fool· 8 months agoThe company sells the top vaccine, Comirnaty, and treatment, Paxlovid. Pfizer's portfolio extends well beyond coronavirus products, with blockbuster...
Pfizer (PFE) to Report Q2 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 11 months agoHigher alliance revenues from Eliquis, higher sales of Prevnar vaccines and drugs like...
Where Will Pfizer Be in 5 Years?
Motley Fool· 9 months agoPfizer (NYSE: PFE) is a company that's in the midst of a transition. The COVID-19 vaccine maker benefited from a huge revenue boost due to the pandemic....
Pfizer Slashed Its Guidance, but Is It Still a Smart Long-Term Buy?
Motley Fool via Yahoo Finance· 6 months agoPer updated guidance for its upcoming 2024 fiscal year, issued on Dec. 13, Pfizer (NYSE: PFE) has a...
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 3 weeks agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (NYSE: PFE) benefitted a few years ago has trickled down to a small stream....
Pfizer: Why its FY2024 downgrade has Wall Street wary
Yahoo Finance· 6 months agoPfizer (PFE) disappointed Wall Street this week with lower revenue guidance for the upcoming year,...
A woman is trying out a 4-dose Lyme disease vaccine as we approach the worst summer for ticks yet
INSIDER via Yahoo News· 12 months agoMindi Weidow and her boyfriend are participating in a Lyme disease vaccine trial. They live in...
UPDATE 6-Pfizer boosts 2022 COVID vaccine forecast, looks to pivot with deals, new drugs
Reuters via Yahoo Finance· 2 years agoPfizer Inc on Tuesday raised its forecast for 2022 sales of its COVID-19 vaccine by $2 billion to $34 billion, and said new deals and drugs in development should help replace future declining ...
